Skip to Main Content

Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population

Conditions

HIV/AIDS | Immune System | Infectious Diseases

What is the purpose of this trial?

Primary:

To describe clinical, immunological, and virological characteristics of persons with acute HIV infection To identify and follow volunteers who may be candidates for future HIV intervention or treatment protocols due to diagnosis of HIV during acute infection
  1. To describe demographics,_aRG-behavioral risk factors and clinical signs and symptoms for those identified with acute HIV infection
  2. To describe neurocognitive function and neuroimaging findings in acute HIV infection as well as describe immune response, HIV-1 genotypes and sequences in the cerebrospinal fluid.
  3. To describe the number and characteristics of sexual contacts
  4. To describe the willingness of acutelv HIV-infected subjects to allow the tracking of their sexual contacts for voluntary HIV counseling and testing (VCT)
  5. To describe immune response, HIV-1 genotypes and sequences in the genital compartment
  6. To describe T. Band NK cell depletion in the gut mucosa in acute HIV infection and describe the changes in gut Hellsimmunity during follow up
  7. To describe T and B cell distribution, phenotype and function in lymph node biopsy samples in acute HIV infection and to describe differences seen in these parameters during study follow up
  8. To understand the association between different HIV reservoir biomarkers
  9. To characterize the composition and evolution of the gastrointestinal microbial population in acutely HIV-infected subjects
  10. To describe virologic and immunologic parameters by different acute HIV infection staging systems (Fiebig, and the 4thG or other staging systems)
  11. To understand the effects of early antiretroviral therapy on the outcomes mentioned above
  12. To archive samples for future investigations including determination of viral burden and evolution, and cell-mediated and humoral immune responses in peripheral blood and mucosal compartments
  • Trial with
    National Institute of Neurological Disorders and Stroke (NINDS)
  • Start Date
    12/07/2011
  • End Date
    12/09/2021
Trial Image

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    06/22/2018
  • Study HIC
    #1111009338